CFM
ACH

Catalyst Funds Management’s Accendra Health ACH Stock Holding History

Catalyst Funds Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$40.5K – 1525
2024
Q2 		$40.5K Buy
+3,000
New +$61.4K 0.01% 475

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Catalyst Funds Management's ACH Position: Q3 2024 in Review

Catalyst Funds Management sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 3,000 shares — an estimated $40.5K sold.

Catalyst Funds Management first reported a position in ACH in Q2 2024 and held it in 1 quarter. The position peaked at $40.5K in Q2 2024. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Catalyst Funds Management reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 3,000 Accendra Health shares in Q3 2024, an estimated $40.5K.
  • Catalyst Funds Management first reported a position in Accendra Health in Q2 2024 and held it in 1 quarter.
  • Catalyst Funds Management's Accendra Health position peaked at $40.5K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Catalyst Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.